| (210) | Number of the EPO application | 18730161 |
| (220) | Filing date of the EPO application | 2018.05.01 |
| (80) | EPO patent specification publication (B) | EPB nr. 42/2023, 2023.10.18 |
| (110) | EPO patent number | 3618842 |
| (21) | Number of the application | e 2020 0252 |
| (71) | Name(s) of applicant(s), code of the country | Juno Therapeutics, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | PORTS Michael, US;
WORKS Melissa, US;
BATUREVYCH Oleksandr, US;
SALMON Ruth, US;
HAUSE Ronald James Jr., US;
JOHNSTONE Timothy G., US;
KUGLER David G., US;
JONES Jon, US;
SONI Neha, US; |
| (73) | Name(s) of owner(s), code of the country | JUNO Therapeutics Inc., US; |
| (54) | Title of the invention | COMBINATION OF A CELL THERAPY AND AN IMMUNOMODULATORY COMPOUND |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 35/17 (2015.01.01); A61K 31/454 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.04.30 |
| (30) | Priority | 201762492947 P, 2017.05.01, US; 201762538670 P, 2017.07.29, US; 201762549390 P, 2017.08.23, US; 201762580433 P, 2017.11.01, US; 201762596753 P, 2017.12.08, US |
| (86) | International application | PCT/US2018/030545, 2018.05.01 |
| (87) | International publication | WO 2018/204427, 2018.11.08 |